Differential Response to Medical Therapy for Male Lower Urinary Tract Symptoms

被引:5
作者
Bechis S.K. [1 ]
Kim M.M. [1 ]
Wintner A. [1 ]
Kreydin E.I. [1 ]
机构
[1] Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
关键词
Benign prostatic hyperplasia; Lower urinary tract symptoms; Medical therapy; Personalized medicine; Risk stratification;
D O I
10.1007/s11884-015-0295-6
中图分类号
学科分类号
摘要
Medical therapy has assumed a critical role in the treatment of male lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction. Targeting both bladder and prostate, these medications provide an effective means to manage LUTS for millions of men. However, significant proportion of men do not respond adequately to medical therapy and go on to surgical treatment of bladder outlet obstruction. In order to provide patients with appropriate therapy, prevent unnecessary exposure to drug side effects, and reduce medical costs, it is important to identify those men in whom medication will not be effective. In this review, we focus on the risk factors that predict failure of the common medical therapies for male LUTS. In addition, we describe recently discovered molecular targets that show promise for treatment of LUTS recalcitrant to conventional therapies. © 2015, Springer Science+Business Media New York.
引用
收藏
页码:177 / 185
页数:8
相关论文
共 50 条
[21]   Tadalafil for male lower urinary tract symptoms improves endothelial function [J].
Fukumoto, Kazuhiko ;
Nagai, Atsushi ;
Hara, Ryoei ;
Fujii, Tomohiro ;
Miyaji, Yoshiyuki .
INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (03) :206-210
[22]   Persistence Rate with Tadalafil for Treatment of Male Lower Urinary Tract Symptoms [J].
Wada, Naoki ;
Kikuchi, Daiki ;
Tateoka, Jo ;
Abe, Noriyuki ;
Watanabe, Masaki ;
Tamaki, Gaku ;
Kita, Masafumi ;
Kakizaki, Hidehiro .
UROLOGIA INTERNATIONALIS, 2020, 104 (5-6) :373-377
[23]   Feasibility of an Alternative Option for the Management of Male Lower Urinary Tract Symptoms [J].
Roehrborn, Claus G. ;
Lowe, Franklin C. ;
Gittelman, Marc ;
Wruck, Jan M. ;
Verbeek, Anna E. .
JOURNAL OF UROLOGY, 2016, 195 (01) :125-130
[24]   New therapeutic strategies for the treatment of male lower urinary tract symptoms [J].
Dimitropoulos, Konstantinos ;
Gravas, Stavros .
RESEARCH AND REPORTS IN UROLOGY, 2016, 8 :51-59
[25]   Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms [J].
Kohn G.E. ;
Kohn T.P. ;
Ramasamy R. .
Current Bladder Dysfunction Reports, 2017, 12 (2) :118-123
[26]   Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms [J].
Fuellhase, Claudius ;
Chapple, Christopher ;
Cornu, Jean-Nicolas ;
De Nunzio, Cosimo ;
Gratzke, Christian ;
Kaplan, Steven A. ;
Marberger, Michael ;
Montorsi, Francesco ;
Novara, Giacomo ;
Oelke, Matthias ;
Porst, Hartmut ;
Roehrborn, Claus ;
Stief, Christian ;
McVary, Kevin T. .
EUROPEAN UROLOGY, 2013, 64 (02) :228-243
[27]   Lower Urinary Tract Symptoms: What's New in Medical Treatment? [J].
Peyronnet, Benoit ;
Brucker, Benjamin M. ;
Michel, Martin C. .
EUROPEAN UROLOGY FOCUS, 2018, 4 (01) :17-24
[28]   Impacts of medical treatments for lower urinary tract symptoms suggestive to benign prostatic hyperplasia on male sexual functions [J].
Huang, Shih-Tsung .
UROLOGICAL SCIENCE, 2016, 27 (01) :3-7
[29]   Persistent use of medical therapy after surgery for lower urinary tract symptoms: a retrospective database analysis [J].
Ory, Jesse ;
Nackeeran, Sirpi ;
Rainer, Quinn ;
Smith, Nicholas ;
Shah, Hemendra ;
Ramasamy, Ranjith .
WORLD JOURNAL OF UROLOGY, 2022, 40 (01) :169-175
[30]   Optimal medical therapy for male urinary symptoms [J].
Welk, Blayne .
BJU INTERNATIONAL, 2020, 125 (06) :E1-E2